Wire Stories
-
590With Japan Embracing Diversity in the Wake of a Successful Paralympic Games, JNTO Introduces the Country�s �Accessible Tourism� Initiatives
TOKYO–(BUSINESS WIRE)–Japan National Tourism Organization (JNTO) is continuing to promote accessible tourism across Japan, aiming to help realize a symbiotic society and...
-
662
Seoul Biennale of Architecture and Urbanism 2021 Is Held on September 16
SEOUL, South Korea–(BUSINESS WIRE)–#CROSSROADS—The Seoul Biennale of Architecture & Urbanism 2021 is opened on September 16 (KST). The Seoul Biennale of Architecture...
-
529
With Japan Embracing Diversity in the Wake of a Successful Paralympic Games, JNTO Introduces the Country�s �Accessible Tourism� Initiatives
TOKYO–(BUSINESS WIRE)–Japan National Tourism Organization (JNTO) is continuing to promote accessible tourism across Japan, aiming to help realize a symbiotic society and...
-
565
Seoul Biennale of Architecture and Urbanism 2021 Is Held on September 16
SEOUL, South Korea–(BUSINESS WIRE)–#CROSSROADS—The Seoul Biennale of Architecture & Urbanism 2021 is opened on September 16 (KST). The Seoul Biennale of Architecture...
-
713
DESTINY-Gastric06 Phase 2 Trial of ENHERTU� Initiated in China in Patients with HER2 Positive Advanced Gastric Cancer
TOKYO & MUNICH & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today announced that the first patient...
-
728
DESTINY-Gastric06 Phase 2 Trial of ENHERTU� Initiated in China in Patients with HER2 Positive Advanced Gastric Cancer
TOKYO & MUNICH & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today announced that the first patient...
-
570
IASO Biotherapeutics Secures $108 Million Series C Funding to Advance Global Development of Innovative Cell Therapies
PLEASANTON, Calif. & NANJING, China & SHANGHAI–(BUSINESS WIRE)–#BioPharmaceutical–IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company focusing on discovering, developing, and manufacturing innovative...
-
628
IASO Biotherapeutics Secures $108 Million Series C Funding to Advance Global Development of Innovative Cell Therapies
PLEASANTON, Calif. & NANJING, China & SHANGHAI–(BUSINESS WIRE)–#BioPharmaceutical–IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company focusing on discovering, developing, and manufacturing innovative...
-
674
Renesas Expands Medical and Industrial Environmental Sensing Portfolio with New Thermopile-Based Detectors for CO2 Sensors
TO-5-Packaged Single- and Dual-Channel Detectors Provide Industry�s Best Performance, Quality, and Longevity for CO2 Sensors TOKYO–(BUSINESS WIRE)–#CO2–Renesas Electronics Corporation (TSE:6723), a premier...
-
566Zai Lab Expands U.S. Operations to Join the Cambridge Biotechnology Community
SHANGHAI and SAN FRANCISCO, Sept. 16, 2021 (GLOBE NEWSWIRE) — Zai Lab Limited�(NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company,�announced today...
